These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18688221)

  • 1. UK strong arms industry over drug pricing.
    Mitchell P
    Nat Biotechnol; 2008 Aug; 26(8):846-7. PubMed ID: 18688221
    [No Abstract]   [Full Text] [Related]  

  • 2. Will UK drug-pricing regulation be abolished?
    Dean M
    Lancet; 1998 Oct; 352(9134):1127. PubMed ID: 9798603
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-Pricing Debate Redux - Should Cost-Effectiveness Analysis Be Used Now to Price Pharmaceuticals?
    Neumann PJ; Cohen JT; Ollendorf DA
    N Engl J Med; 2021 Nov; 385(21):1923-1924. PubMed ID: 34767318
    [No Abstract]   [Full Text] [Related]  

  • 4. The 340B Drug Pricing Program: an opportunity for savings, if covered entities such as disproportionate share hospitals and federally qualified health centers know how to interpret the regulations.
    Werling K; Abraham S; Strelec J
    Health Care Law Mon; 2007 Aug; ():3-12. PubMed ID: 17955590
    [No Abstract]   [Full Text] [Related]  

  • 5. New drug pricing scheme could politicise decisions and reduce access, says think tank.
    O'Dowd A
    BMJ; 2013 May; 346():f2965. PubMed ID: 23657194
    [No Abstract]   [Full Text] [Related]  

  • 6. Limiting Free Pricing of New Innovative Drugs After Launch: A Necessity for Payers?
    Gandjour A
    Appl Health Econ Health Policy; 2016 Oct; 14(5):507-9. PubMed ID: 27262556
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmaceutical industry pricing practices: impact of the Bayer settlement.
    Berkle M
    Health Care Law Mon; 2001 Jul; ():3-11. PubMed ID: 11484634
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulating the price of the UK's drugs: second thoughts after the government's first report.
    Earl-Slater A
    BMJ; 1997 Feb; 314(7077):365-8. PubMed ID: 9040338
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulating the pharmaceutical industry. Authors seem to have misunderstood pharmaceutical price regulation scheme.
    Read P
    BMJ; 1998 Jan; 316(7126):226; author reply 228. PubMed ID: 9468700
    [No Abstract]   [Full Text] [Related]  

  • 10. The 340B Drug Pricing Program: an opportunity for savings, if covered entities such as disproportionate share hospitals and federally qualified health centers know how to interpret the regulations.
    Werling K; Abraham S; Strelec J
    J Health Care Finance; 2007; 34(2):57-70. PubMed ID: 18972994
    [No Abstract]   [Full Text] [Related]  

  • 11. The Canadians are killing us.
    Struble RA
    Pharos Alpha Omega Alpha Honor Med Soc; 2002; 65(4):58-9. PubMed ID: 12592981
    [No Abstract]   [Full Text] [Related]  

  • 12. Time to fix the price fix.
    Earl-Slater A
    Health Serv J; 1997 Nov; 107(5578):22-3. PubMed ID: 10174008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American pharmaceutical prices.
    Alagona P
    Pharos Alpha Omega Alpha Honor Med Soc; 2002; 65(4):58. PubMed ID: 12592980
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceutical costs. An overview and analysis of legal and policy responses by the states.
    Latham SR
    J Leg Med; 2003 Jun; 24(2):141-73. PubMed ID: 12775406
    [No Abstract]   [Full Text] [Related]  

  • 15. The pharmaceutical industry--prices and progress.
    Scherer FM
    N Engl J Med; 2004 Aug; 351(9):927-32. PubMed ID: 15329432
    [No Abstract]   [Full Text] [Related]  

  • 16. The government's drug pricing policy is falling apart messily.
    Hawkes N
    BMJ; 2013 Jun; 346():f3634. PubMed ID: 23741032
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug pricing. AHF: Schwarzenegger bows to drug industry donations.
    AIDS Policy Law; 2005 Oct; 20(19):4. PubMed ID: 16276597
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharma focus. Market traders.
    Lewis C
    Health Serv J; 2003 Nov; 113(5883):suppl 2-3. PubMed ID: 14671865
    [No Abstract]   [Full Text] [Related]  

  • 19. UK, Germany, dissociate from WHO drug pricing resolution.
    Zarocostas J
    Lancet; 2019 Jun; 393(10188):2287. PubMed ID: 31180020
    [No Abstract]   [Full Text] [Related]  

  • 20. How much "spread" in AWP pricing is unlawful?
    Rubinstein E; Curtiss FR
    J Manag Care Pharm; 2007; 13(6):515-6. PubMed ID: 17672813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.